| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.29 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.24 | 0.08 |